Infections as Novel Risk Factors of Atherosclerotic Cardiovascular Diseases: Pathophysiological Links and Therapeutic Implications
Review
[키워드] acute respiratory syndrome
Administered
Angiotensin-converting enzyme
anti-cytokine
anti-infective drug
Anti-inflammatory
association
Atherosclerosis
blockers
cardiovascular
cardiovascular disease
Colchicine
coronavirus
cytomegalovirus
determine
disease
drug
drugs
early diagnosis
Evidence
Factor
heart muscle
Helicobacter pylori
herpes simplex virus
Human
immunodeficiency virus
implication
increased risk
Infection
Infection prevention
infections
Inflammation
management
methotrexate
Mortality
novel
outcomes
P2Y12
pathogen
Patient
persist
Pneumonia
progression
proinflammatory
receptor
receptor inhibitors
reduction
residual risk
risk factor
Risk factors
therapeutic
therapy
Treatment
triggering
vasculature
viral infection
[DOI] 10.3390/jcm10122539 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/jcm10122539 PMC 바로가기 [Article Type] Review